Page results
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
UCLH is celebrating the delivery of its 1,000th respiratory syncytial virus (RSV) vaccine to pregnant women, following the rollout of the new national programme in September.
File results
-
FOI/2022/0611 - FTE staff, student staff, patients and attendances, bed numbers and occupancy
-
FOI/2022/0612 - Blood transfusions from patients vaccinated with mRNA gene therapy Coronavirus
-
FOI/2022/0615 - Vasectomy operations
-
FOI/2022/0616 - Corporate property and asset information facilities management
-
FOI/2022/0623 - Integration/ workflow solutions across multiple technology systems
-
FOI/2022/0625 - Lung cancer treatment
-
FOI/2022/0624 - ICT contract(s) for server hardware maintenance/ server virtualisation licenses
-
FOI/2022/0626 - Anaesthetists employed at Trust
-
FOI/2022/0628 - Diagnostic tests in pathology laboratory
-
FOI/2022/0630 - Patients exclusion at Trust hospitals